Black Diamond Therapeutics Inc (BDTX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -24.1M | -21.56M | -20.03M | -24.01M | -20.86M | -20.25M | -22.13M | -18.13M |
Pre Tax Income | -21.08M | -20.88M | -19.15M | -23.01M | -19.41M | -18.23M | -19.91M | -15.56M |
Net Income | -21.08M | -20.88M | -19.15M | -23.01M | -19.41M | -18.23M | -19.91M | -15.56M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -21.76M | -21.5M | -19.63M | -23.45M | -19.73M | -18.86M | -20.37M | -16.07M |
EBITDA | -23.98M | -21.44M | -19.92M | -23.9M | -20.77M | -20.16M | -22.04M | -18.04M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.12M | -8.9M | -29.33M | -69.57M | -126.87M | -95.08M | -86.46M |
Pre Tax Income | -4.6M | -8.93M | -35.26M | -67.25M | -125.6M | -91.17M | -82.44M |
Net Income | -4.6M | -8.93M | -35.26M | -67.25M | -125.6M | -91.17M | -82.44M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
EBIT | -4.41M | -8.92M | -29.33M | -71.29M | -129.06M | -93.2M | -84.37M |
EBITDA | -4.1M | -8.86M | -29.29M | -69.52M | -126.67M | -94.57M | -86.02M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.